Clinical Study on Bronchial asthma.

Phase 4

Not yet recruiting

Conditions: Other and unspecified asthma,

Registration Number: CTRI/2022/05/042522

Lead Sponsor: Vinayaka Mission Homeopathic Medical College and Hospital

Brief Summary: | |

| --- |

|Bronchial asthma is characterized by chronic airway inflammation and increased airway responsiveness leading to symptoms of wheeze, cough and dyspnea. The prevalence of asthma is increasing steadily. Asthma ranks amongst the most common chronic ailments of the globe. It is estimated that 300 million people worldwide suffer from asthma. Annually 250,000 deaths are attributed to asthma, and its complications. In our country, the disease is under recognized and underrated. The WHO estimates that asthma contributes to the loss of 15 million disability-adjusted life years.

The prevalence of asthma has increased markedly over the past 30 years. In developed countries, approximately 10% of adults and 15% of children have asthma. The majority of asthmatics have childhood onset of disease. Asthma often starts early in life. The prevalence of asthma is increasing in all age group, despite major advances in understanding the etiology and pathophysiology of asthma and development of new therapeutic modalities to control symptoms and prevent exacerbations, effective therapies are not widely used.

Homoeopathy hasa vital role in the treatment of asthma. . Hence, I selected the topic â€œTHE EFFICACY OF HOMEOPATHIC SIMILLIMUM ON TREATING ATOPICBRONCHIAL ASTHMA WITH AN EVALUATION BASED ON SERUM IgEâ€

Detailed Description: Not available

Recruitment & Eligibility

Status: Not Yet Recruiting

Sex: All

Target Recruitment: 30

Inclusion Criteria

Patient selected from age 5 to 60 and patients with clinical presentation of Bronchial asthma and Patients with strong family history and previous atopic History.

Exclusion Criteria

Patients suffering from other respiratory diseases Patients suffering from other systemic diseases.

Study & Design

Study Type: Interventional

Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Serum IgE	after 6 months

Secondary Outcome Measures

Name	Time	Method
It is expected that the proposed study will be useful in reducing the symptoms of Bronchial asthma and to improve the quality of life of the patients.	After 6 months

Trial Locations

Locations (1): Vinayaka Mission Homoeopathic Medical College and Hospital
🇮🇳
Salem, TAMIL NADU, India
Vinayaka Mission Homoeopathic Medical College and Hospital
🇮🇳Salem, TAMIL NADU, India
Dr E Nisha Paul
Principal investigator
9995680275
Nisha.gopal2012@gmail.com